http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102050800-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_72dacf4ff825940489434f2fbec05053
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-096
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-096
filingDate 2009-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2013-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44032be594499b86f609cd37a5100e0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08b48312253725222f045c5ac6f539e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7064a03701643e18ce7220540eb823b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d06e1b16234e77b947f9de78504a65e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a623ba64a7e43cc5e7244f9bbb3671c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94813ae1a53f57fcd0406fd514ad1402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9996f43fc74bebb5fcdfab35cd23e63
publicationDate 2013-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102050800-B
titleOfInvention Method for preparing optical isomers of 1-butyl-2-hydroxyarylalkanol piperazine derivative
abstract The invention relates to a method for preparing (1S and 2S) and (1R and 2R) optical isomers of 1-butyl-2-hydroxyarylalkanol piperazine derivative, particularly N1-benzyl-N4-[1-butyl-2-(5'-chloro-6'-methoxy-2'-naphthyl) hydroxyethyl] piperazine (shown as a formula A) and diastereoisomer salts formed by the optical isomers and a splitting reagent. The method comprises the following steps of: dissolving mixture of (1S and 2S) and (1R and 2R) formula A compound optical isomers, particularly raceme and chiral mandelic acid or derivatives thereof in a proper solvent to perform reaction, settling the generated (1S and 2S)-forma A compound-R-(-)-mandelic acid or derivative salt thereof or (1R and 2R)-forma A compound-S-(+)-mandelic acid or derivative salt thereof respectively, and then performing alkalization to obtain corresponding (1S and 2S) or (1R and 2R) forma A compound optical isomers.
priorityDate 2009-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419566664
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6991974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416081552
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456029861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5771688
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556587
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15413
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547105
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416060943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID328
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1292
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549439
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8254
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546724
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559482
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410554239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419565385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID688349
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID785085
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3839223
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15930710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051571
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455695671
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6337
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559052
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453924777
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID440639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457280508
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457192620
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584556
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419589248

Total number of triples: 78.